Clinical Trial Update: The Effect of Oral Administration of Hesperidin and Diosmin in Reducing Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether oral hesperidin and diosmin can reduce paclitaxel-induced peripheral neuropathy in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Diosmin (Diosmin)
• Hesperidin (Hesperidin)

Snippet

Sponsor: Alexandria University | Conditions: Breast Cancer | Phase 3 | Status: NOT_YET_RECRUITING